Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues
A study on how the newest modulator medication elexacaftor/tezacaftor/ivacaftor affects the gut over time using MRI scans
Comparing the money spent on healthcare up to age 2 years in children with CF who are screen detected and those who are diagnosed later due to sickness.
Differences between the United States and the European Union in the time of approval of CFTR modulators for the treatment of cystic fibrosis
